25 XP   0   0   10

TransMedics Group Inc
Buy, Hold or Sell?

Let's analyse Transmedics together

PenkeI guess you are interested in TransMedics Group Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of TransMedics Group Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about TransMedics Group Inc

I send you an email if I find something interesting about TransMedics Group Inc.

Quick analysis of Transmedics (30 sec.)










What can you expect buying and holding a share of Transmedics? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.01
Expected worth in 1 year
$2.30
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$-1.71
Return On Investment
-1.9%

For what price can you sell your share?

Current Price per Share
$89.25
Expected price per share
$68.84 - $99.63
How sure are you?
50%

1. Valuation of Transmedics (5 min.)




Live pricePrice per Share (EOD)

$89.25

Intrinsic Value Per Share

$-57.02 - $-67.45

Total Value Per Share

$-53.01 - $-63.44

2. Growth of Transmedics (5 min.)




Is Transmedics growing?

Current yearPrevious yearGrowGrow %
How rich?$137.2m$121.5m$28.8m19.2%

How much money is Transmedics making?

Current yearPrevious yearGrowGrow %
Making money-$6.2m-$9m$2.8m44.8%
Net Profit Margin-10.4%-43.2%--

How much money comes from the company's main activities?

3. Financial Health of Transmedics (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#124 / 334

Most Revenue
#98 / 334

Most Profit
#233 / 334

Most Efficient
#155 / 334

What can you expect buying and holding a share of Transmedics? (5 min.)

Welcome investor! Transmedics's management wants to use your money to grow the business. In return you get a share of Transmedics.

What can you expect buying and holding a share of Transmedics?

First you should know what it really means to hold a share of Transmedics. And how you can make/lose money.

Speculation

The Price per Share of Transmedics is $89.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Transmedics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Transmedics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.01. Based on the TTM, the Book Value Change Per Share is $-0.43 per quarter. Based on the YOY, the Book Value Change Per Share is $0.91 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Transmedics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.120.1%-0.19-0.2%-0.28-0.3%-0.26-0.3%-0.24-0.3%
Usd Book Value Change Per Share0.150.2%-0.43-0.5%0.911.0%0.210.2%0.170.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.150.2%-0.43-0.5%0.911.0%0.210.2%0.170.2%
Usd Price Per Share78.93-73.35-40.46-35.88-29.90-
Price to Earnings Ratio167.31--192.86--41.07--58.99--49.16-
Price-to-Total Gains Ratio530.65-212.27--1,101.15--236.02--236.02-
Price to Book Ratio19.66-16.40-13.24-11.43-9.53-
Price-to-Total Gains Ratio530.65-212.27--1,101.15--236.02--236.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share89.25
Number of shares11
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.430.21
Usd Total Gains Per Share-0.430.21
Gains per Quarter (11 shares)-4.712.29
Gains per Year (11 shares)-18.859.16
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-19-2909-1
20-38-480188
30-57-6702717
40-75-8603726
50-94-10504635
60-113-12405544
70-132-14306453
80-151-16207362
90-170-18108271
100-188-20009280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%1.023.00.04.2%1.023.00.04.2%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%6.017.01.025.0%6.017.01.025.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.024.00.0%0.00.024.00.0%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%6.017.01.025.0%6.017.01.025.0%

Fundamentals of Transmedics

About TransMedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-12 20:12:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of TransMedics Group Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Transmedics earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Transmedics to the Medical Devices industry mean.
  • A Net Profit Margin of 5.0% means that $0.05 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of TransMedics Group Inc:

  • The MRQ is 5.0%. The company is making a profit. +1
  • The TTM is -10.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ5.0%TTM-10.4%+15.4%
TTM-10.4%YOY-43.2%+32.9%
TTM-10.4%5Y-96.4%+86.0%
5Y-96.4%10Y-111.4%+15.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0%-12.4%+17.4%
TTM-10.4%-20.4%+10.0%
YOY-43.2%-14.4%-28.8%
5Y-96.4%-21.3%-75.1%
10Y-111.4%-25.0%-86.4%
1.1.2. Return on Assets

Shows how efficient Transmedics is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Transmedics to the Medical Devices industry mean.
  • 0.6% Return on Assets means that Transmedics generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of TransMedics Group Inc:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -1.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.6%TTM-1.0%+1.6%
TTM-1.0%YOY-5.9%+4.8%
TTM-1.0%5Y-6.2%+5.1%
5Y-6.2%10Y-6.8%+0.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6%-4.1%+4.7%
TTM-1.0%-4.7%+3.7%
YOY-5.9%-4.6%-1.3%
5Y-6.2%-4.0%-2.2%
10Y-6.8%-5.2%-1.6%
1.1.3. Return on Equity

Shows how efficient Transmedics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Transmedics to the Medical Devices industry mean.
  • 2.9% Return on Equity means Transmedics generated $0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of TransMedics Group Inc:

  • The MRQ is 2.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -4.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ2.9%TTM-4.8%+7.7%
TTM-4.8%YOY-11.9%+7.1%
TTM-4.8%5Y-10.1%+5.3%
5Y-10.1%10Y-8.4%-1.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9%-4.2%+7.1%
TTM-4.8%-5.8%+1.0%
YOY-11.9%-5.5%-6.4%
5Y-10.1%-6.3%-3.8%
10Y-8.4%-7.1%-1.3%

1.2. Operating Efficiency of TransMedics Group Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Transmedics is operating .

  • Measures how much profit Transmedics makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Transmedics to the Medical Devices industry mean.
  • An Operating Margin of 3.2% means the company generated $0.03  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of TransMedics Group Inc:

  • The MRQ is 3.2%. The company is operating less efficient.
  • The TTM is -11.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ3.2%TTM-11.6%+14.8%
TTM-11.6%YOY-37.4%+25.9%
TTM-11.6%5Y-87.7%+76.1%
5Y-87.7%10Y-100.2%+12.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2%-24.3%+27.5%
TTM-11.6%-16.4%+4.8%
YOY-37.4%-14.0%-23.4%
5Y-87.7%-20.4%-67.3%
10Y-100.2%-24.8%-75.4%
1.2.2. Operating Ratio

Measures how efficient Transmedics is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.97 means that the operating costs are $0.97 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of TransMedics Group Inc:

  • The MRQ is 0.968. The company is less efficient in keeping operating costs low.
  • The TTM is 1.116. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.968TTM1.116-0.148
TTM1.116YOY1.374-0.259
TTM1.1165Y1.866-0.751
5Y1.86610Y1.990-0.124
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9681.456-0.488
TTM1.1161.439-0.323
YOY1.3741.431-0.057
5Y1.8661.436+0.430
10Y1.9901.374+0.616

1.3. Liquidity of TransMedics Group Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Transmedics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 9.30 means the company has $9.30 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of TransMedics Group Inc:

  • The MRQ is 9.296. The company is very able to pay all its short-term debts. +2
  • The TTM is 12.516. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.296TTM12.516-3.220
TTM12.516YOY8.045+4.471
TTM12.5165Y9.016+3.500
5Y9.01610Y8.000+1.016
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ9.2962.693+6.603
TTM12.5162.697+9.819
YOY8.0453.504+4.541
5Y9.0163.617+5.399
10Y8.0003.499+4.501
1.3.2. Quick Ratio

Measures if Transmedics is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Transmedics to the Medical Devices industry mean.
  • A Quick Ratio of 8.34 means the company can pay off $8.34 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of TransMedics Group Inc:

  • The MRQ is 8.344. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 11.530. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.344TTM11.530-3.185
TTM11.530YOY7.941+3.589
TTM11.5305Y11.166+0.364
5Y11.16610Y9.414+1.752
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ8.3441.516+6.828
TTM11.5301.658+9.872
YOY7.9412.142+5.799
5Y11.1662.307+8.859
10Y9.4142.370+7.044

1.4. Solvency of TransMedics Group Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Transmedics assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Transmedics to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.81 means that Transmedics assets are financed with 80.6% credit (debt) and the remaining percentage (100% - 80.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of TransMedics Group Inc:

  • The MRQ is 0.806. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.685. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.806TTM0.685+0.120
TTM0.685YOY0.431+0.254
TTM0.6855Y0.508+0.177
5Y0.50810Y0.545-0.037
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8060.402+0.404
TTM0.6850.389+0.296
YOY0.4310.335+0.096
5Y0.5080.442+0.066
10Y0.5450.461+0.084
1.4.2. Debt to Equity Ratio

Measures if Transmedics is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Transmedics to the Medical Devices industry mean.
  • A Debt to Equity ratio of 414.6% means that company has $4.15 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of TransMedics Group Inc:

  • The MRQ is 4.146. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.210. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.146TTM3.210+0.936
TTM3.210YOY0.829+2.381
TTM3.2105Y1.186+2.024
5Y1.18610Y0.988+0.198
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1460.559+3.587
TTM3.2100.560+2.650
YOY0.8290.479+0.350
5Y1.1860.614+0.572
10Y0.9880.674+0.314

2. Market Valuation of TransMedics Group Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Transmedics generates.

  • Above 15 is considered overpriced but always compare Transmedics to the Medical Devices industry mean.
  • A PE ratio of 167.31 means the investor is paying $167.31 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of TransMedics Group Inc:

  • The EOD is 189.189. Based on the earnings, the company is expensive. -2
  • The MRQ is 167.313. Based on the earnings, the company is expensive. -2
  • The TTM is -192.861. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD189.189MRQ167.313+21.876
MRQ167.313TTM-192.861+360.174
TTM-192.861YOY-41.069-151.792
TTM-192.8615Y-58.990-133.871
5Y-58.99010Y-49.159-9.832
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD189.189-1.021+190.210
MRQ167.313-1.704+169.017
TTM-192.861-2.081-190.780
YOY-41.069-2.980-38.089
5Y-58.990-2.379-56.611
10Y-49.159-1.726-47.433
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of TransMedics Group Inc:

  • The EOD is -22.755. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -20.124. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -45.876. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-22.755MRQ-20.124-2.631
MRQ-20.124TTM-45.876+25.752
TTM-45.876YOY-31.041-14.835
TTM-45.8765Y-29.473-16.403
5Y-29.47310Y-24.561-4.912
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-22.755-0.981-21.774
MRQ-20.124-1.578-18.546
TTM-45.876-2.973-42.903
YOY-31.041-6.179-24.862
5Y-29.473-4.928-24.545
10Y-24.561-5.060-19.501
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Transmedics is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 19.66 means the investor is paying $19.66 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of TransMedics Group Inc:

  • The EOD is 22.234. Based on the equity, the company is expensive. -2
  • The MRQ is 19.663. Based on the equity, the company is expensive. -2
  • The TTM is 16.402. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD22.234MRQ19.663+2.571
MRQ19.663TTM16.402+3.261
TTM16.402YOY13.241+3.161
TTM16.4025Y11.432+4.970
5Y11.43210Y9.527+1.905
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD22.2341.930+20.304
MRQ19.6632.372+17.291
TTM16.4022.444+13.958
YOY13.2413.205+10.036
5Y11.4323.893+7.539
10Y9.5274.245+5.282
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of TransMedics Group Inc.

3.1. Institutions holding TransMedics Group Inc

Institutions are holding 111.862% of the shares of TransMedics Group Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31FMR Inc14.75990.029348287441138742.4152
2023-12-31BlackRock Inc7.79530.005125502551009254.1205
2023-12-31Vanguard Group Inc5.7010.00321865115506732.7928
2023-12-31Macquarie Group Ltd4.66390.13911525819-185032-10.8152
2023-12-31Fred Alger Management, LLC4.10490.57191342915-231688-14.7141
2023-12-31Amvescap Plc.3.48720.02141140851-112568-8.9809
2023-12-31Driehaus Capital Management LLC3.33331.03691090507895958.9513
2023-12-31Lord, Abbett & Co LLC3.13480.2907102556435247052.3656
2023-12-31ArrowMark Colorado Holdings, LLC (ArrowMark Partners)3.12040.8894102083827779837.3867
2023-12-31Eventide Asset Management, LLC3.03911.2809994240688847.4441
2023-12-31Credit Suisse First Boston (CSFB)2.62710.0654859478-272425-24.0679
2023-12-31Goldman Sachs Group Inc2.42870.0056794566436234121.7402
2023-12-31State Street Corporation2.40580.0037870782840.0361
2023-12-31Sandhill Capital Partners LLC2.33295.0055763201305914.1756
2023-12-31First Light Asset Management, LLC2.30574.7975431713621722.038
2023-12-31Allspring Global Investments Holdings, LLC2.1650.0927708273-563370-44.3025
2023-12-31Geode Capital Management, LLC2.14170.0058700674347515.2185
2023-12-31Bank of New York Mellon Corp2.10.011687025-73074-9.6137
2023-12-31Bellevue Group AG1.58610.6265518890-17847-3.3251
2023-12-31Emerald Advisers, LLC1.57831.74435163537380716.6778
Total 74.811116.617724474703+310099+1.3%

3.2. Funds holding TransMedics Group Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Fidelity Advisor Growth Opps M3.37340.50721103617-21200-1.8848
2024-01-31Vanguard Total Stock Mkt Idx Inv30.005798144817030.1738
2023-12-31Macquarie US Small Cap Core Equity2.51330.8682822240-140093-14.5576
2024-01-31Delaware Small Cap Core I2.48350.9848812500-9740-1.1846
2024-02-29iShares Russell 2000 ETF2.34980.1006768734-126-0.0164
2023-12-31Eventide Gilead N2.25571.522273794610000015.6753
2024-01-31CS (Lux) Digital Health Equity SB USD2.06333.8321675000-125000-15.625
2023-12-31Fidelity Small Cap Growth2.03660.920966629000
2024-01-31Lord Abbett Developing Growth A1.65592.0094541749-6881-1.2542
2024-01-31Vanguard Institutional Extnd Mkt Idx Tr1.47760.04314834081640.0339
2024-01-31Fidelity OTC1.28290.134241970000
2023-11-30MEDICAL BioHealth EUR Acc1.26654.733941432800
2023-12-31Vanguard Explorer Inv1.25040.15140906914710356.1535
2023-12-31Fidelity Series Small Cap Opps1.20510.570539424700
2024-01-31Bellevue (Lux) Bellevue Dgtl Hthl I2 EUR1.2057.80939420400
2023-12-31American Century U.S. Small Cap Growth1.16310.93733805186883822.0861
2023-12-31American Century Small Cap Growth Inv1.16310.93713805186883822.0861
2023-12-31Canada Life US Small-Mid Cap Growth F0.99971.153232706100
2023-12-31Delaware Ivy Small Cap Growth C0.99821.873332655000
2023-12-31Fidelity Small Cap Index0.96510.098131573439521.2676
Total 34.708229.191811354861+87558+0.8%

3.3. Insider Transactions

Insiders are holding 3.637% of the shares of TransMedics Group Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-09Tamer I KhayalSELL1551290.45
2024-04-04Tamer I KhayalSELL494780.36
2024-04-01Stephen GordonSELL1500074.01
2024-03-08Stephen GordonSELL190387.63
2024-03-08Tamer I KhayalSELL141787.8
2024-03-04Stephen GordonSELL1500082.8
2024-03-01James R TobinSELL1338083.63
2024-03-01Tamer I KhayalSELL1000082.99
2024-02-20Tamer I KhayalSELL25090
2024-02-15Tamer I KhayalSELL77690
2024-02-07Tamer I KhayalSELL73690.09
2024-02-06Edward M BasileSELL715786.38
2024-02-01Stephen GordonSELL1500085.45
2024-01-23Tamer I KhayalSELL233090.09
2024-01-16Tamer I KhayalSELL1000080.41
2024-01-02Stephen GordonSELL1500077.07
2023-12-13Miriam ProvostSELL412275.1
2023-11-28James R TobinSELL1000070.14
2023-11-07Waleed H HassaneinSELL1500064.32
2023-10-02Stephen GordonSELL500054.22

4. Summary

4.1. Key Performance Indicators

The key performance indicators of TransMedics Group Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.149-0.428+388%0.913-84%0.208-29%0.167-11%
Book Value Per Share--4.0144.552-12%3.714+8%3.004+34%2.510+60%
Current Ratio--9.29612.516-26%8.045+16%9.016+3%8.000+16%
Debt To Asset Ratio--0.8060.685+18%0.431+87%0.508+59%0.545+48%
Debt To Equity Ratio--4.1463.210+29%0.829+400%1.186+250%0.988+320%
Dividend Per Share----0%-0%-0%-0%
Eps--0.118-0.193+263%-0.277+335%-0.257+318%-0.245+308%
Free Cash Flow Per Share---0.981-1.457+49%-0.441-55%-0.526-46%-0.472-52%
Free Cash Flow To Equity Per Share---0.9541.603-159%0.842-213%0.602-258%0.496-292%
Gross Profit Margin--1.0001.354-26%1.703-41%1.229-19%1.198-17%
Intrinsic Value_10Y_max---67.450--------
Intrinsic Value_10Y_min---57.023--------
Intrinsic Value_1Y_max---3.430--------
Intrinsic Value_1Y_min---3.367--------
Intrinsic Value_3Y_max---12.842--------
Intrinsic Value_3Y_min---12.209--------
Intrinsic Value_5Y_max---25.314--------
Intrinsic Value_5Y_min---23.277--------
Market Cap2919840525.000+8%2697753126.8702428469091.218+11%1323742826.250+104%1179585331.244+129%982987776.036+174%
Net Profit Margin--0.050-0.104+309%-0.432+971%-0.964+2042%-1.114+2344%
Operating Margin--0.032-0.116+460%-0.374+1267%-0.877+2834%-1.002+3224%
Operating Ratio--0.9681.116-13%1.374-30%1.866-48%1.990-51%
Pb Ratio22.234+12%19.66316.402+20%13.241+49%11.432+72%9.527+106%
Pe Ratio189.189+12%167.313-192.861+215%-41.069+125%-58.990+135%-49.159+129%
Price Per Share89.250+12%78.93073.348+8%40.463+95%35.880+120%29.900+164%
Price To Free Cash Flow Ratio-22.755-13%-20.124-45.876+128%-31.041+54%-29.473+46%-24.561+22%
Price To Total Gains Ratio600.030+12%530.648212.274+150%-1101.149+308%-236.017+144%-236.017+144%
Quick Ratio--8.34411.530-28%7.941+5%11.166-25%9.414-11%
Return On Assets--0.006-0.010+283%-0.059+1128%-0.062+1178%-0.068+1295%
Return On Equity--0.029-0.048+264%-0.119+507%-0.101+444%-0.084+387%
Total Gains Per Share--0.149-0.428+388%0.913-84%0.208-29%0.167-11%
Usd Book Value--137202000.000150375000.000-9%121515250.000+13%98563450.000+39%82353958.333+67%
Usd Book Value Change Per Share--0.149-0.428+388%0.913-84%0.208-29%0.167-11%
Usd Book Value Per Share--4.0144.552-12%3.714+8%3.004+34%2.510+60%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.118-0.193+263%-0.277+335%-0.257+318%-0.245+308%
Usd Free Cash Flow---33514000.000-48021750.000+43%-14431000.000-57%-17268250.000-48%-15490291.667-54%
Usd Free Cash Flow Per Share---0.981-1.457+49%-0.441-55%-0.526-46%-0.472-52%
Usd Free Cash Flow To Equity Per Share---0.9541.603-159%0.842-213%0.602-258%0.496-292%
Usd Market Cap2919840525.000+8%2697753126.8702428469091.218+11%1323742826.250+104%1179585331.244+129%982987776.036+174%
Usd Price Per Share89.250+12%78.93073.348+8%40.463+95%35.880+120%29.900+164%
Usd Profit--4031000.000-6257000.000+255%-9057750.000+325%-8388450.000+308%-7980208.333+298%
Usd Revenue--81174000.00060405750.000+34%23364750.000+247%20729350.000+292%17816833.333+356%
Usd Total Gains Per Share--0.149-0.428+388%0.913-84%0.208-29%0.167-11%
 EOD+5 -3MRQTTM+20 -14YOY+18 -165Y+17 -1710Y+17 -17

4.2. Fundamental Score

Let's check the fundamental score of TransMedics Group Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15189.189
Price to Book Ratio (EOD)Between0-122.234
Net Profit Margin (MRQ)Greater than00.050
Operating Margin (MRQ)Greater than00.032
Quick Ratio (MRQ)Greater than18.344
Current Ratio (MRQ)Greater than19.296
Debt to Asset Ratio (MRQ)Less than10.806
Debt to Equity Ratio (MRQ)Less than14.146
Return on Equity (MRQ)Greater than0.150.029
Return on Assets (MRQ)Greater than0.050.006
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of TransMedics Group Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.053
Ma 20Greater thanMa 5086.090
Ma 50Greater thanMa 10083.234
Ma 100Greater thanMa 20082.092
OpenGreater thanClose87.760
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income before Tax  -6,7014,076-2,6251,645-980-25,949-26,92930,7923,863
Net Income  -6,7204,084-2,6361,635-1,001-24,421-25,42229,4534,031
EBIT  -6,7794,690-2,0891,183-906-27,429-28,33530,9382,603
Operating Income  -6,7794,690-2,0891,183-906-27,429-28,33530,9382,603
Net Interest Income  -1,007-84-1,091-1,414-2,505-1,085-3,59012,4858,895
Net Income from Continuing Operations  -6,7204,084-2,6361,635-1,001-24,421-25,42229,4534,031



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets706,047
Total Liabilities568,845
Total Stockholder Equity137,202
 As reported
Total Liabilities 568,845
Total Stockholder Equity+ 137,202
Total Assets = 706,047

Assets

Total Assets706,047
Total Current Assets510,654
Long-term Assets195,393
Total Current Assets
Cash And Cash Equivalents 394,812
Net Receivables 63,576
Inventory 44,235
Other Current Assets 8,031
Total Current Assets  (as reported)510,654
Total Current Assets  (calculated)510,654
+/-0
Long-term Assets
Property Plant Equipment 180,487
Goodwill 11,990
Intangible Assets 2,354
Long-term Assets Other 62
Long-term Assets  (as reported)195,393
Long-term Assets  (calculated)194,893
+/- 500

Liabilities & Shareholders' Equity

Total Current Liabilities54,934
Long-term Liabilities513,911
Total Stockholder Equity137,202
Total Current Liabilities
Short-term Debt 2,035
Accounts payable 12,717
Other Current Liabilities 38,221
Total Current Liabilities  (as reported)54,934
Total Current Liabilities  (calculated)52,973
+/- 1,961
Long-term Liabilities
Long term Debt 506,204
Capital Lease Obligations Min Short Term Debt7,707
Long-term Liabilities  (as reported)513,911
Long-term Liabilities  (calculated)513,911
+/-0
Total Stockholder Equity
Common Stock641,106
Retained Earnings -503,705
Accumulated Other Comprehensive Income -199
Total Stockholder Equity (as reported)137,202
Total Stockholder Equity (calculated)137,202
+/-0
Other
Capital Stock641,106
Cash and Short Term Investments 394,812
Common Stock Shares Outstanding 34,179
Current Deferred Revenue1,961
Liabilities and Stockholders Equity 706,047
Net Debt 121,134
Net Invested Capital 643,406
Net Working Capital 455,720
Property Plant and Equipment Gross 201,780
Short Long Term Debt Total 515,946



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
> Total Assets 
0
51,134
48,397
42,157
38,759
121,014
112,618
105,299
96,923
163,137
159,322
152,026
145,783
140,512
131,146
134,893
124,008
117,285
274,873
277,147
287,088
690,358
689,227
706,047
706,047689,227690,358287,088277,147274,873117,285124,008134,893131,146140,512145,783152,026159,322163,13796,923105,299112,618121,01438,75942,15748,39751,1340
   > Total Current Assets 
0
47,477
43,081
34,794
30,059
116,133
107,366
100,001
91,704
158,227
154,126
146,766
140,543
135,052
125,577
118,705
105,795
95,113
250,586
252,294
261,730
662,655
536,724
510,654
510,654536,724662,655261,730252,294250,58695,113105,795118,705125,577135,052140,543146,766154,126158,22791,704100,001107,366116,13330,05934,79443,08147,4770
       Cash And Cash Equivalents 
0
34,439
28,890
20,241
12,215
47,242
20,407
20,092
24,738
51,152
21,397
24,581
26,727
25,314
22,495
25,580
17,897
30,386
204,462
201,182
195,375
582,210
427,110
394,812
394,812427,110582,210195,375201,182204,46230,38617,89725,58022,49525,31426,72724,58121,39751,15224,73820,09220,40747,24212,21520,24128,89034,4390
       Short-term Investments 
0
750
0
0
0
48,995
67,865
60,596
47,816
88,223
111,317
101,061
91,386
86,935
80,360
66,872
54,104
27,697
0
0
0
0
0
0
00000027,69754,10466,87280,36086,93591,386101,061111,31788,22347,81660,59667,86548,9950007500
       Net Receivables 
0
2,748
3,904
3,438
5,146
7,105
6,465
6,559
6,133
4,431
6,141
6,864
7,395
6,271
4,150
5,934
11,724
12,979
22,035
27,611
38,620
47,524
60,654
63,576
63,57660,65447,52438,62027,61122,03512,97911,7245,9344,1506,2717,3956,8646,1414,4316,1336,5596,4657,1055,1463,4383,9042,7480
       Other Current Assets 
0
0
0
1,838
1,404
1,571
2,093
1,538
1,656
1,866
2,287
2,326
3,215
3,525
3,703
5,460
5,356
6,583
5,514
2,896
3,774
2,376
9,595
8,031
8,0319,5952,3763,7742,8965,5146,5835,3565,4603,7033,5253,2152,3262,2871,8661,6561,5382,0931,5711,4041,838000
   > Long-term Assets 
0
0
0
7,363
8,700
4,881
5,252
5,298
5,219
4,910
5,196
5,260
5,240
5,460
5,569
16,188
18,213
22,172
24,287
24,853
25,358
27,703
152,503
195,393
195,393152,50327,70325,35824,85324,28722,17218,21316,1885,5695,4605,2405,2605,1964,9105,2195,2985,2524,8818,7007,363000
       Property Plant Equipment 
0
3,151
3,342
3,474
3,750
4,375
4,746
4,792
4,713
4,404
4,690
4,754
4,734
4,954
5,063
15,688
17,713
21,672
23,787
24,353
24,100
26,894
137,865
180,487
180,487137,86526,89424,10024,35323,78721,67217,71315,6885,0634,9544,7344,7544,6904,4044,7134,7924,7464,3753,7503,4743,3423,1510
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,673
11,990
11,99011,6730000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,405
2,354
2,3542,4050000000000000000000000
       Other Assets 
0
506
1,974
3,889
4,950
506
506
506
506
506
506
506
506
506
506
500
500
500
500
500
0
809
0
0
0080905005005005005005065065065065065065065065065064,9503,8891,9745060
> Total Liabilities 
0
43,681
45,799
46,982
51,278
49,853
49,146
50,650
50,240
49,377
49,772
48,135
48,108
51,529
52,597
67,039
64,098
66,366
87,016
89,772
94,463
545,145
562,767
568,845
568,845562,767545,14594,46389,77287,01666,36664,09867,03952,59751,52948,10848,13549,77249,37750,24050,65049,14649,85351,27846,98245,79943,6810
   > Total Current Liabilities 
0
9,273
11,359
12,553
16,201
15,377
14,641
16,115
15,039
13,818
13,624
11,879
11,757
15,079
15,923
23,238
20,256
22,741
20,689
23,661
28,635
32,017
49,101
54,934
54,93449,10132,01728,63523,66120,68922,74120,25623,23815,92315,07911,75711,87913,62413,81815,03916,11514,64115,37716,20112,55311,3599,2730
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
34,787
34,921
0
8,604
1,337
1,372
1,407
1,444
1,481
1,880
1,985
2,035
2,0351,9851,8801,4811,4441,4071,3721,3378,604034,92134,787000000000000
       Accounts payable 
0
2,742
3,689
4,720
5,499
6,662
4,766
7,247
4,860
3,722
778
1,206
1,289
2,389
2,682
6,651
2,934
5,711
3,080
3,341
4,329
7,031
12,836
12,717
12,71712,8367,0314,3293,3413,0805,7112,9346,6512,6822,3891,2891,2067783,7224,8607,2474,7666,6625,4994,7203,6892,7420
       Other Current Liabilities 
0
512
500
7,527
10,343
8,540
9,713
8,702
10,015
9,076
11,499
10,410
10,036
12,217
12,921
16,337
15,738
15,420
15,976
18,635
22,581
22,862
31,651
38,221
38,22131,65122,86222,58118,63515,97615,42015,73816,33712,92112,21710,03610,41011,4999,07610,0158,7029,7138,54010,3437,5275005120
   > Long-term Liabilities 
0
0
0
34,429
35,077
34,476
34,505
34,535
35,201
35,559
36,148
36,256
36,351
36,450
36,674
43,801
43,842
43,625
66,327
66,111
65,828
513,128
513,666
513,911
513,911513,666513,12865,82866,11166,32743,62543,84243,80136,67436,45036,35136,25636,14835,55935,20134,53534,50534,47635,07734,429000
       Long term Debt Total 
0
0
0
33,670
33,785
33,902
34,023
34,146
34,269
0
0
34,657
34,787
34,921
35,058
35,197
35,334
35,475
58,540
0
58,802
0
0
0
00058,802058,54035,47535,33435,19735,05834,92134,78734,6570034,26934,14634,02333,90233,78533,670000
       Other Liabilities 
0
963
876
759
667
574
482
389
932
1,164
1,623
1,599
1,564
1,529
1,616
0
0
0
0
0
0
0
0
0
0000000001,6161,5291,5641,5991,6231,1649323894825746677598769630
       Deferred Long Term Liability 
0
0
1,468
3,383
4,444
0
0
0
0
0
0
1,599
1,564
1,529
1,616
0
0
0
0
0
0
0
0
0
0000000001,6161,5291,5641,5990000004,4443,3831,46800
> Total Stockholder Equity
-168,724
-179,659
-184,697
-4,825
-12,519
71,161
63,472
54,649
46,683
113,760
109,550
103,891
97,675
88,983
78,549
67,854
59,910
50,919
187,857
187,375
192,625
145,213
126,460
137,202
137,202126,460145,213192,625187,375187,85750,91959,91067,85478,54988,98397,675103,891109,550113,76046,68354,64963,47271,161-12,519-4,825-184,697-179,659-168,724
   Common Stock
0
1
1
331,212
1
423,245
423,758
424,134
424,791
500,556
501,486
502,217
503,912
505,933
508,458
510,488
513,203
515,756
660,061
666,277
674,156
627,747
634,458
641,106
641,106634,458627,747674,156666,277660,061515,756513,203510,488508,458505,933503,912502,217501,486500,556424,791424,134423,758423,2451331,212110
   Retained Earnings Total Equity000-481,3130-471,957-464,531-453,008-442,446-429,778-416,816-406,148-398,23100000000000
   Accumulated Other Comprehensive Income 
0
0
0
-101
-67
-58
20
-2
227
36
-16
-95
-89
-134
-131
-188
-285
-306
-247
-225
-218
-220
-262
-199
-199-262-220-218-225-247-306-285-188-131-134-89-95-1636227-220-58-67-101000
   Capital Surplus 
0
0
0
143,794
143,859
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000143,859143,794000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
-150
-138
-101
329,753
-121,014
-112,618
-2
227
36
-16
-95
-89
-134
-131
68,042
-285
-306
-247
-225
-218
0
0
0
000-218-225-247-306-28568,042-131-134-89-95-1636227-2-112,618-121,014329,753-101-138-1500



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue241,623
Cost of Revenue-87,630
Gross Profit153,993153,993
 
Operating Income (+$)
Gross Profit153,993
Operating Expense-153,508
Operating Income485485
 
Operating Expense (+$)
Research Development36,055
Selling General Administrative119,553
Selling And Marketing Expenses2,100
Operating Expense153,508157,708
 
Net Interest Income (+$)
Interest Income12,500
Interest Expense-10,791
Other Finance Cost-9,902
Net Interest Income-8,193
 
Pretax Income (+$)
Operating Income485
Net Interest Income-8,193
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-26,67127,641
EBIT - interestExpense = -10,306
-26,671
-14,237
Interest Expense10,791
Earnings Before Interest and Taxes (EBIT)485-15,880
Earnings Before Interest and Taxes (EBITDA)8,762
 
After tax Income (+$)
Income Before Tax-26,671
Tax Provision--1,456
Net Income From Continuing Ops-35,779-25,215
Net Income-25,028
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses241,138
Total Other Income/Expenses Net-27,1568,193
 

Technical Analysis of Transmedics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Transmedics. The general trend of Transmedics is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Transmedics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of TransMedics Group Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 97.78 < 99.63.

The bearish price targets are: 69.91 > 69.43 > 68.84.

Tweet this
TransMedics Group Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of TransMedics Group Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

TransMedics Group Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of TransMedics Group Inc. The current macd is 2.28932394.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Transmedics price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Transmedics. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Transmedics price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
TransMedics Group Inc Daily Moving Average Convergence/Divergence (MACD) ChartTransMedics Group Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of TransMedics Group Inc. The current adx is 23.60.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Transmedics shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
TransMedics Group Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of TransMedics Group Inc. The current sar is 95.33.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
TransMedics Group Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of TransMedics Group Inc. The current rsi is 56.05. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
TransMedics Group Inc Daily Relative Strength Index (RSI) ChartTransMedics Group Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of TransMedics Group Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Transmedics price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
TransMedics Group Inc Daily Stochastic Oscillator ChartTransMedics Group Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of TransMedics Group Inc. The current cci is 28.09.

TransMedics Group Inc Daily Commodity Channel Index (CCI) ChartTransMedics Group Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of TransMedics Group Inc. The current cmo is 11.92.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
TransMedics Group Inc Daily Chande Momentum Oscillator (CMO) ChartTransMedics Group Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of TransMedics Group Inc. The current willr is -57.20992622.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Transmedics is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
TransMedics Group Inc Daily Williams %R ChartTransMedics Group Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of TransMedics Group Inc.

TransMedics Group Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of TransMedics Group Inc. The current atr is 4.87656138.

TransMedics Group Inc Daily Average True Range (ATR) ChartTransMedics Group Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of TransMedics Group Inc. The current obv is 44,435.

TransMedics Group Inc Daily On-Balance Volume (OBV) ChartTransMedics Group Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of TransMedics Group Inc. The current mfi is 56.51.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
TransMedics Group Inc Daily Money Flow Index (MFI) ChartTransMedics Group Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for TransMedics Group Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

TransMedics Group Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of TransMedics Group Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.053
Ma 20Greater thanMa 5086.090
Ma 50Greater thanMa 10083.234
Ma 100Greater thanMa 20082.092
OpenGreater thanClose87.760
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Transmedics with someone you think should read this too:
  • Are you bullish or bearish on Transmedics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Transmedics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about TransMedics Group Inc

I send you an email if I find something interesting about TransMedics Group Inc.


Comments

How you think about this?

Leave a comment

Stay informed about TransMedics Group Inc.

Receive notifications about TransMedics Group Inc in your mailbox!